• Profile
Close

Acetyl-CoA synthetase 2 enhances tumorigenesis and is indicative of a poor prognosis for patients with renal cell carcinoma

Urologic Oncology: Seminars and Original Investigations Mar 07, 2018

Zhang S, et al. - Acetyl-CoA synthetase 2 (ACSS2) expression and function in renal cell carcinoma (RCC) were determined using immunohistochemistry, and the clinicopathologic correlation and prognostic relevance were evaluated. Cell-based functional assays demonstrated that RCC cell growth, migration, and invasion are inhibited by ACSS2 knockdown, whereas overexpression of ACSS2 enhanced these effects. It was noted that ACSS2 increases RCC progression and aggressive behavior and is an independent prognostic factor.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay